Canaccord Genuity Starts Gemphire Therapeutics (GEMP) at Buy

August 30, 2016 6:40 AM EDT
Get Alerts GEMP Hot Sheet
Price: $10.32 -1.24%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade GEMP Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Canaccord Genuity initiated coverage on Gemphire Therapeutics (NASDAQ: GEMP) with a Buy rating and a price target of $17.00.

For an analyst ratings summary and ratings history on Gemphire Therapeutics click here. For more ratings news on Gemphire Therapeutics click here.

Shares of Gemphire Therapeutics closed at $10.15 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Canaccord Genuity

Add Your Comment